Taylor Strange, DO
Ophthalmology · Fort Worth, TXNPI 1023336633
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Lensar, Inc. at 53.4% of the total. 2025 is the largest year on record at $68,163, more than ten times the $3,796 reported in 2019. Among ophthalmology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 647 payments — averaging $277.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lensar, Inc.$96K
- Rxsight Inc$46K
- Johnson & Johnson Surgical Vision, Inc.$19K
- Carl Zeiss Meditec USA, Inc.$4K
- Glaukos Corporation$3K
- AbbVie$2K
- plus $9K from 30 others
Across 17 payments — averaging $11,097 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$189K
What the payments were for
- Consulting fees$99,40755%
- Speaking & faculty fees$20,26711%
- Travel & lodging$2540%
- Food & beverage$59,25733%
- Education$50%
- Gifts$1020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LENSAR LASER SYSTEM$95,138
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$32,136
- Tecnis IOL$14,748
- Tecnis Simplicity$14,035
- RXSIGHT CONTACT LENS$12,801
- RXSIGHT INJECTOR CARTRIDGE$12,801
- RXSIGHT INJECTOR HANDPIECE$12,801
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$12,801
- LIGHT ADJUSTABLE LENS (LAL)$10,438
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$2,363
- Tecnis Symfony IOL$2,132
- QUATERA 700$1,540
- CALLISTO eye$1,540
- CIRRUS HD-OCT$1,540
- CIRRUS 6000 with AngioPlex$1,540
- DEXTENZA$1,500
- Travoprost Intraocular Implant - iDose$1,400
- ARTEVO 800$820
- iDoseTR$285
- Ahmed Glaucoma Valve$279
How this compares
$179,293 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 11 | $3,952 |
| Prednisolone Acetate | 37 | $1,755 |
| Ibuprofen | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLCProlensa | $847 | $3,95211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,355 ophthalmology providers in Texas.
Other ophthalmology in Fort Worth
- Brett MuellerFort Worth$160K
- Brian FlowersFort Worth$156K
- Michael SingerSan Antonio$1.8M
- Oluwatosin SmithDallas$1.5M
- Charles WykoffBellaire$1.5M
- John MichelettiHouston$916K
- Davinder GroverDallas$705K
- Christina WengHouston$676K
- Peter ChangHouston$656K
- Zaina Al-MohtasebHouston$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.